Arcutis Biotherapeutics (ARQT) Work In Process (2022 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Work In Process of $6.3 million for Q1 2026, up 708.56% year-over-year from $783000.0 in Q1 2025, and up 25.79% quarter-over-quarter from $5.0 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Work In Process (2022 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Work In Process history runs 5 years deep, the most recent figure standing at $6.3 million for Q1 2026.
- In Q1 2026, Work In Process rose 708.56% year-over-year to $6.3 million; the TTM figure through Mar 2026 stood at $6.3 million (up 708.56% YoY), while the FY2025 annual figure was $5.0 million, up 761.82% from the prior year.
- Work In Process for Q1 2026 stood at $6.3 million, up from $5.0 million in the prior quarter.
- The five-year high for Work In Process was $6.3 million in Q1 2026, with the low at $116000.0 in Q3 2022.
- The 5-year median for Work In Process is $783000.0 (2025), against an average of $1.8 million.
- The sharpest annual moves came in 2024 and 2025: Work In Process soared 1158.47% in 2024, then slumped 66.0% in 2025.
- Arcutis Biotherapeutics' Work In Process stood at $395000.0 in 2022, then increased by 23.04% to $486000.0 in 2023, then grew by 20.16% to $584000.0 in 2024, then jumped by 761.82% to $5.0 million in 2025, then increased by 25.79% to $6.3 million in 2026.
- Business Quant data shows ARQT's Work In Process at $6.3 million in Q1 2026, $5.0 million in Q4 2025, and $4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.78 Mn |
| Mar 31, 2026 | 6.33 Mn |
| Dec 31, 2025 | 5.03 Mn |
| Sep 30, 2025 | 4.73 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 783,000.00 |
| Dec 31, 2024 | 584,000.00 |
| Sep 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 1.97 Mn |
| Mar 31, 2024 | 2.30 Mn |
| Dec 31, 2023 | 486,000.00 |
| Sep 30, 2023 | 367,000.00 |
| Jun 30, 2023 | 569,000.00 |
| Mar 31, 2023 | 183,000.00 |
| Dec 31, 2022 | 395,000.00 |
| Sep 30, 2022 | 116,000.00 |